Artwork

Sisällön tarjoaa Dr Jim Kantidakis. Dr Jim Kantidakis tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
Player FM - Podcast-sovellus
Siirry offline-tilaan Player FM avulla!

Ep 17 Assoc Prof Jason Tye-Din on Coeliac Disease

1:00:56
 
Jaa
 

Manage episode 238824222 series 1437856
Sisällön tarjoaa Dr Jim Kantidakis. Dr Jim Kantidakis tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.

Dr Tye-Din is a gastroenterologist with a clinical and research interest in Coeliac disease. He heads the Coeliac Research Lab at the Walter and Eliza Hall Institute, runs a Coeliac clinic at the Royal Melbourne Hospital and is an Honorary Research Fellow at the Murdoch Children’s Research Institute. His PhD employed feeding studies to characterise gluten immunity that underpinned development of a novel immunotherapy for Coeliac disease, Nexvax2.

His research interests include understanding the immune and genetic basis for coeliac disease and how gluten tolerance is lost, the role of the microbiome, understanding why the gluten-free diet can fail, and developing and testing novel diagnostics and treatments. He is on the editorial board of Alimentary Pharmacology and Therapeutics and consults for an industry partner (ImmusanT Inc.) who are leading the development of Nexvax2. Jason chairs the Medical Advisory Committee of Coeliac Australia and is involved in patient advocacy, clinical guideline development and medical education.

In todays talk, we covered a lot. There was so much about coeliac disease that I didn’t know, and so, I think a lot of people, medical professionals as well as individuals managing this disease, will find this episode really interesting and helpful.

So what did we cover?

We talked about

  1. What Coeliac disease is?
  2. Its Incidence and prevalence ?
  3. Age of onset ?
  4. What the symptoms are ?
  5. The potential complications of undiagnosed untreated coeliac disease?
  6. Why a gluten free diet may sometimes be unsuccessful in reducing complications
  7. The different ways to diagnose Coeliac disease?
  8. Why Coeliac disease can be under diagnosed
  9. The overlap between Coeliac disease and functional gut disorders
  10. The difference between Coeliac disease and Non-Coeliac Gluten Hypersensitivity
  11. We also talking about his exciting new research in developing a vaccine, called the Nexvax2
  12. We talked about the research looking at utilising the hook worm to manage the disease
  13. What is important for a person managing Coeliac disease or newly diagnosed to know?
  14. What would be take home message for health professionals ?

and...a whole lot more...

Please enjoy my conversation with Dr Jason Tye-Din

  continue reading

30 jaksoa

Artwork
iconJaa
 
Manage episode 238824222 series 1437856
Sisällön tarjoaa Dr Jim Kantidakis. Dr Jim Kantidakis tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.

Dr Tye-Din is a gastroenterologist with a clinical and research interest in Coeliac disease. He heads the Coeliac Research Lab at the Walter and Eliza Hall Institute, runs a Coeliac clinic at the Royal Melbourne Hospital and is an Honorary Research Fellow at the Murdoch Children’s Research Institute. His PhD employed feeding studies to characterise gluten immunity that underpinned development of a novel immunotherapy for Coeliac disease, Nexvax2.

His research interests include understanding the immune and genetic basis for coeliac disease and how gluten tolerance is lost, the role of the microbiome, understanding why the gluten-free diet can fail, and developing and testing novel diagnostics and treatments. He is on the editorial board of Alimentary Pharmacology and Therapeutics and consults for an industry partner (ImmusanT Inc.) who are leading the development of Nexvax2. Jason chairs the Medical Advisory Committee of Coeliac Australia and is involved in patient advocacy, clinical guideline development and medical education.

In todays talk, we covered a lot. There was so much about coeliac disease that I didn’t know, and so, I think a lot of people, medical professionals as well as individuals managing this disease, will find this episode really interesting and helpful.

So what did we cover?

We talked about

  1. What Coeliac disease is?
  2. Its Incidence and prevalence ?
  3. Age of onset ?
  4. What the symptoms are ?
  5. The potential complications of undiagnosed untreated coeliac disease?
  6. Why a gluten free diet may sometimes be unsuccessful in reducing complications
  7. The different ways to diagnose Coeliac disease?
  8. Why Coeliac disease can be under diagnosed
  9. The overlap between Coeliac disease and functional gut disorders
  10. The difference between Coeliac disease and Non-Coeliac Gluten Hypersensitivity
  11. We also talking about his exciting new research in developing a vaccine, called the Nexvax2
  12. We talked about the research looking at utilising the hook worm to manage the disease
  13. What is important for a person managing Coeliac disease or newly diagnosed to know?
  14. What would be take home message for health professionals ?

and...a whole lot more...

Please enjoy my conversation with Dr Jason Tye-Din

  continue reading

30 jaksoa

Kaikki jaksot

×
 
Loading …

Tervetuloa Player FM:n!

Player FM skannaa verkkoa löytääkseen korkealaatuisia podcasteja, joista voit nauttia juuri nyt. Se on paras podcast-sovellus ja toimii Androidilla, iPhonela, ja verkossa. Rekisteröidy sykronoidaksesi tilaukset laitteiden välillä.

 

Pikakäyttöopas